Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI is a research paper published in Journal of Cystic Fibrosis (2022). On theSindex it has a DataRank of 4.1. It has been cited 125 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.725
From this paper's citation signal
Citation Network Contribution
3.4
From 76 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
Cystic Fibrosis Foundation
Grant: NCT04038047
FWCI
14.56
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords